Show simple item record

dc.contributor.authorOzekmekci, Sibel
dc.contributor.authorErginoz, Ethem
dc.contributor.authorDelil, Sakir
dc.contributor.authorApaydin, Hulya
dc.contributor.authorBenbir, Gulcin
dc.date.accessioned2021-03-03T20:57:23Z
dc.date.available2021-03-03T20:57:23Z
dc.date.issued2006
dc.identifier.citationBenbir G., Ozekmekci S., Apaydin H., Delil S., Erginoz E., "A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy", CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.108, sa.8, ss.726-732, 2006
dc.identifier.issn0303-8467
dc.identifier.otherav_5cac873b-4b3a-489b-af41-6962cb7c73ff
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/64956
dc.identifier.urihttps://doi.org/10.1016/j.clineuro.2006.02.002
dc.description.abstractObjectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectTıp
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleA hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy
dc.typeMakale
dc.relation.journalCLINICAL NEUROLOGY AND NEUROSURGERY
dc.contributor.department, ,
dc.identifier.volume108
dc.identifier.issue8
dc.identifier.startpage726
dc.identifier.endpage732
dc.contributor.firstauthorID180485


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record